Increased Expression of Phosphatidylcholine (16:0/18:1) and (16:0/18:2) in Thyroid Papillary Cancer

@inproceedings{Ishikawa2012IncreasedEO,
  title={Increased Expression of Phosphatidylcholine (16:0/18:1) and (16:0/18:2) in Thyroid Papillary Cancer},
  author={Seiji Ishikawa and Ichiro Tateya and Takahiro Hayasaka and Noritaka Masaki and Yoshinori Takizawa and Satoshi Ohno and Tsuyoshi Kojima and Yoshiharu Kitani and Morimasa Kitamura and Shigeru Hirano and Mitsutoshi Setou and Juichi Ito},
  booktitle={PloS one},
  year={2012}
}
A good prognosis can be expected for most, but not all, cases of thyroid papillary cancer. Numerous molecular studies have demonstrated beneficial treatment and prognostic factors in various molecular markers. Whereas most previous reports have focused on genomics and proteomics, few have focused on lipidomics. With the advent of mass spectrometry (MS), it has become possible to identify many types of molecules, and this analytical tool has become critical in the field of omics. Recently… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 22 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 31 references

Similar Papers

Loading similar papers…